ArticleHealth care science2026
Long-Term Trends and Projections of the Global Epilepsy Burden: Insights From the Global Burden of Disease Study 2021.
Article in Health care science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-Term Trends and Projections of the Global Epilepsy Burden: Insights From the Global Burden of Disease Study 2021.Health care science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epilepsy is a common neurological disorder imposing significant global health burdens. A comprehensive understanding of its temporal and spatial trends is critical for informing policies and guiding interventions. Methods: This study assessed the burden of epilepsy from 1990 to 2021 worldwide, in Asia, and in China, and projected trends to 2050. We used data from the Global Burden of Disease 2021 study to evaluate the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) related to epilepsy. Joinpoint regression, age-period-cohort analysis, and autoregressive integrated moving average forecasting were used to examine temporal trends and project future patterns. We also assessed the influence of socioeconomic development, health service coverage, and risk factors on the epilepsy burden, focusing on regional disparities. Results: From 1990 to 2021, the incidence and prevalence of epilepsy showed a significant upward trend, while mortality and DALY rates showed a significant downward trend. China exhibited sharper reductions in mortality (average annual percent change = -2.64) and DALY rates (average annual percent change = -1.79). Inequalities persist, with low socio-demographic index countries showing a disproportionately higher epilepsy burden. In China, improved universal health coverage and socioeconomic development are correlated with a decreasing burden. Alcohol use remains a key modifiable risk factor, particularly among men. Projections suggest a continued shift in the epilepsy burden toward older adults, with those aged ≥ 70 years contributing the largest share of future cases. Conclusions: Epilepsy remains a major global health concern with a substantial and uneven disease burden. Comprehensive burden analyses are essential for guiding public health policy, optimizing resource allocation, and developing targeted prevention and intervention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.